AAPL 190.415 0.3663% MSFT 422.65 -0.1016% GOOG 175.36 0.8512% GOOGL 174.14 0.9449% AMZN 185.71 -0.1505% NVDA 943.46 -0.3001% META 473.555 -1.6582% TSLA 174.87 0.5058% TSM 154.06 -0.977% LLY 776.1758 -1.3779% V 280.145 -0.2972% AVGO 1436.4972 0.0228% JPM 204.205 1.0366% UNH 522.225 0.9033% NVO 133.03 -1.2105% WMT 63.485 6.109% LVMUY 170.79 -0.2511% XOM 117.87 -0.5988% LVMHF 855.728 -0.1473% MA 461.6867 0.805%

Zivo Bioscience Inc

Healthcare US ZIVO

7.98USD
0.15(1.92%)

Last update at 2024-05-15T19:35:00Z

Day Range

7.987.98
LowHigh

52 Week Range

0.4822.50
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -8.74529M -9.16337M -9.10573M -11.51017M -14.63537M
Minority interest - - - - -
Net income -8.74529M -9.39665M -9.65578M -14.66798M -14.63537M
Selling general administrative 6.49M 6.93M 4.82M 6.05M 3.32M
Selling and marketing expenses - - - - -
Gross profit - - 0.02M - 0.00000M
Reconciled depreciation - - - - 0.00000M
Ebit -8.73197M -9052.60500M -9.10573M -8.35235M -6.13064M
Ebitda -8.73197M -9.05260M -8.55568M -8.35235M -6.53813M
Depreciation and amortization - -0.55575M 0.00062M - -0.40749M
Non operating income net other - - - -3.15782M -8.50472M
Operating income -8.73197M -9.05260M -8.55568M -8.35235M -6.13064M
Other operating expenses 8.73M 9.05M 8.58M 8.35M 6.13M
Interest expense 0.01M 0.23M 0.55M 3.16M 8.10M
Tax provision - - - - -
Interest income - - - - -
Net interest income -0.01332M -0.23328M -0.55005M -3.15782M -8.50472M
Extraordinary items - - - - -
Non recurring - - 2.87M 1.97M 1.96M
Other items - - - - -
Income tax expense - 0.23M 0.55M 3.16M 0.41M
Total revenue 0.00000M 0.00000M 0.02M 0.00000M 0.00000M
Total operating expenses 8.73M 9.05M 8.58M 8.35M 6.13M
Cost of revenue - - - - 0.00000M
Total other income expense net -0.01332M -0.11076M -0.55005M -3.15782M -8.50472M
Discontinued operations - - - - -
Net income from continuing ops -8.74529M -9.16337M -9.10573M -11.51017M -14.63537M
Net income applicable to common shares -8.74529M -9.16337M -9.10573M -11.51017M -14.63537M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 2.12M 8.99M 0.22M 0.37M 0.41M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets 0.10M 58.08M 29.95M 0.02M 0.02M
Total liab 2.13M 2.95M 11.53M 8.71M 22.69M
Total stockholder equity -0.01062M 6.04M -11.31061M -8.33848M -22.28212M
Deferred long term liab - - - - -
Other current liab 1.20M 2.04M 2.68M 2.06M 4.12M
Common stock 0.00942M 0.00942M 0.41M 0.40M 0.18M
Capital stock 0.00942M 0.00942M 0.41M 0.40M 0.18M
Retained earnings -115.80453M -108.22704M -99.06368M -89.95795M -78.44778M
Other liab - - - - -
Good will - - - - -
Other assets 0.03M 0.00300M 0.00300M - -
Cash 1.80M 8.90M 0.14M 0.35M 0.39M
Cash and equivalents - - - - -
Total current liabilities 2.03M 2.95M 11.39M 8.71M 22.69M
Current deferred revenue - - 1.94M - -
Net debt -1.35408M -8.64670M 5.22M 4.93M 17.77M
Short term debt 0.34M 0.26M 5.22M 5.28M 18.15M
Short long term debt 0.24M 0.24M 5.19M 5.28M 18.15M
Short long term debt total 0.45M 0.26M 5.36M 5.28M 18.15M
Other stockholder equity 115.78M 114.26M 87.34M 81.22M 56.09M
Property plant equipment 0.19M 0.03M 0.05M - -
Total current assets 1.90M 8.96M 0.17M 0.37M 0.41M
Long term investments - - - - -
Net tangible assets -0.01062M 6.04M -11.31061M -8.33848M -22.28212M
Short term investments - - - - -
Net receivables - - - - -
Long term debt - - 0.12M - -
Inventory - - - - -
Accounts payable 0.49M 0.65M 1.56M 1.37M 0.42M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - -0.10000M -0.10000M
Additional paid in capital - - - - -
Common stock total equity - - 0.41M 0.40M 0.18M
Preferred stock total equity - - - - -
Retained earnings total equity - - -99.06368M -89.95795M -78.44778M
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.03M 0.00300M 0.00300M 0.00000M 0.00000M
Deferred long term asset charges - - - - -
Non current assets total 0.22M 0.03M 0.05M 0.00000M 0.00000M
Capital lease obligations 0.21M 0.02M 0.04M - -
Long term debt total - - 0.12M - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Change to liabilities -0.16366M -0.81999M 0.84M 0.95M -0.11929M
Total cashflows from investing activities - - - - -
Net borrowings - - 0.25M 0.03M 1.75M
Total cash from financing activities -0.62860M 15.57M 2.38M 3.66M 5.08M
Change to operating activities -0.19173M 0.43M 0.64M 1.52M 2.05M
Net income -8.74529M -9.16337M -9.10573M -11.51017M -14.63537M
Change in cash -7.10261M 8.76M -0.20825M -0.04278M 0.07M
Begin period cash flow 8.90M 0.14M 0.35M 0.39M 0.32M
End period cash flow 1.80M 8.90M 0.14M 0.35M 0.39M
Total cash from operating activities -7.10261M -6.80333M -2.58841M -3.70730M -5.00659M
Issuance of capital stock 0.00000M 17.21M 0.40M 2.65M 3.43M
Depreciation -0.77402M -555.74500M 0.00062M 1.19M 5.09M
Other cashflows from investing activities - - - - -
Dividends paid - - - - -
Change to inventory - - - - -
Change to account receivables - - - - -
Sale purchase of stock - - 0.40M 2.65M 3.43M
Other cashflows from financing activities 0.63M -1.45163M 1.98M 1.05M 1.86M
Change to netincome 2.00M 2.75M 3.85M 0.76M 0.82M
Capital expenditures 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Change receivables - - - - -
Cash flows other operating - - 1.83M 0.00067M 0.00747M
Exchange rate changes - - - - -
Cash and cash equivalents changes - - -0.20825M -0.04278M 0.07M
Change in working capital -0.35539M -0.39413M 2.67M 2.47M 1.93M
Stock based compensation 2.69M 3.38M - - -
Other non cash items 0.08M -0.62335M 3.85M 4.15M 2.61M
Free cash flow -7.10261M -6.80333M -2.58841M -3.70730M -5.00659M

Fundamentals

  • Previous Close 7.83
  • Market Cap2.40M
  • Volume4
  • P/E Ratio-
  • Dividend Yield4.24%
  • Revenue TTM0.02M
  • Revenue Per Share TTM0.01
  • Gross Profit TTM 0.02M
  • Diluted EPS TTM-5.33

Peer Comparison

Sector: Healthcare Industry: Biotechnology

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
ZIVO
Zivo Bioscience Inc
0.15 1.92% 7.98 - - 159.57 21.13 169.85 -0.3363
NVO
Novo Nordisk A/S
-1.63 1.21% 133.03 41.58 31.15 2.13 32.99 2.11 4.70
NONOF
Novo Nordisk A/S
0.57 0.43% 132.69 41.06 31.25 2.08 33.11 2.11 4.70
VRTX
Vertex Pharmaceuticals Inc
1.20 0.27% 438.69 30.40 24.75 10.68 6.25 9.52 20.36
CSLLY
CSL Ltd
1.03 1.09% 96.00 42.45 26.95 7.05 5.80 7.85 26.51

Reports Covered

Stock Research & News

Profile

ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. Its products indications include poultry gut health, bovine mastitis, canine joint health, human immune modification, algal biomass for human consumption, and biomass for supporting skin health / anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Bloomfield Hills, Michigan.

Zivo Bioscience Inc

21 East Long Lake Road, Bloomfield Hills, MI, United States, 48304

Key Executives

Name Title Year Born
Mr. John B. Payne Pres, CEO & Chairman 1948
Mr. Keith R. Marchiando CFO, Treasurer & Sec. 1962

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).